论文部分内容阅读
格列美脲（elimepiride）是类似格列本脲（glibenclamide）和格列吡嗪（glipizide）的一种新的磺酰脲类药物，近期在美国上市用于治疗节制饮食和从事运动而未能控制的Ⅱ型糖尿病。这是FDA批准的第一种可与胰岛素同时使用的磺酰脲类药物。1作用机理和药动学磺酸腺类可刺激胰腺分
Elimepiride is a new sulfonylurea similar to glibenclamide and glipizide, recently marketed in the United States for the treatment of controlled diet and physical activity but failed Control of type II diabetes. This is the first FDA-approved sulfonylurea that can be used with insulin. 1 Mechanism of action and pharmacokinetics Sulphate gland stimulates the pancreas